| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |